TipRanks
Advertisement

NL:WSRI ETF Price & Analysis

Compare

WSRI ETF Chart & Stats

$137.79
--
Market closed
$137.79
--

ETF Overview

Amundi Index MSCI World SRI PAB -UCITS ETF DR C- Capitalisation

The Amundi Index MSCI World SRI PAB - UCITS ETF DR C - Capitalisation, with the ticker FR:WSRI, is a meticulously crafted investment vehicle designed for those seeking a conscientious approach to global equity markets. This ETF is firmly anchored in the Size and Style category, with a distinct focus on the Extended Market within a Broad-based niche. By concentrating on the Extended Market, the ETF offers exposure beyond the conventional blue-chip stocks, delving into mid-cap and small-cap companies that are often the engines of innovation and growth. Investors are provided with a diversified portfolio that captures the dynamism of emerging leaders across various sectors on a global scale. The ETF's core objective is to replicate the performance of the MSCI World SRI PAB Index, integrating Environmental, Social, and Governance (ESG) criteria to ensure alignment with sustainable investment principles. This socially responsible investing (SRI) framework excludes companies with controversial business practices, focusing instead on those demonstrating superior ESG performance relative to their peers. Furthermore, the ETF adheres to the Paris-Aligned Benchmark (PAB) standards, targeting a significant reduction in carbon intensity, which aligns with the global transition towards a low-carbon economy. This makes it an ideal choice for investors who are not only looking for financial returns but also wish to contribute positively to environmental sustainability. In summary, the Amundi Index MSCI World SRI PAB - UCITS ETF DR C - Capitalisation offers a unique blend of extended market exposure and ethical investment principles, appealing to investors who are committed to fostering a sustainable future while capitalizing on the potential of diverse global markets.

Amundi Index MSCI World SRI PAB -UCITS ETF DR C- Capitalisation (WSRI) Fund Flow Chart

Amundi Index MSCI World SRI PAB -UCITS ETF DR C- Capitalisation (WSRI) 1 year Net Flows: -$151M

WSRI ETF News

WSRI ETF FAQ

What was NL:WSRI’s price range in the past 12 months?
NL:WSRI lowest ETF price was $112.76 and its highest was $143.02 in the past 12 months.
    What is the AUM of NL:WSRI?
    As of Oct 13, 2026 The AUM of NL:WSRI is 3.76B.
      Is NL:WSRI overvalued?
      According to Wall Street analysts NL:WSRI’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does NL:WSRI pay dividends?
        NL:WSRI does not currently pay dividends.
        How many shares outstanding does NL:WSRI have?
        Currently, no data Available
        Which hedge fund is a major shareholder of NL:WSRI?
        Currently, no hedge funds are holding shares in NL:WSRI

        WSRI ETF Smart Score

        For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

        Top 10 Holdings

        Name
        Weight %
        Nvidia Corporation
        5.84%
        ASML Holding NV
        5.19%
        Applied Materials, Inc.
        3.63%
        Lam Research Corp
        3.62%
        Visa Inc.
        3.01%
        Palo Alto Networks
        2.91%
        Marvell Technology Group
        2.11%
        Analog Devices, Inc.
        2.03%
        Walt Disney Company
        1.65%
        Home Depot
        1.59%
        Total31.59%
        See All Holdings
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Advertisement